Results 221 to 230 of about 45,189 (317)

Pregnancy Outcomes of Targeted Synthetic Disease-Modifying Antirheumatic Drugs Among Patients With Autoimmune Diseases: A Scoping Review. [PDF]

Arthritis Care Res (Hoboken)
Cheng V, Amiri N, Cheng V, Ellis U, Cragg JJ, Harrison M, Proulx L, De Vera MA.   +7 more
europepmc   +1 more source

Biological Disease-Modifying Antirheumatic Drugs Decrease Uric Acid Levels in the Sera of Patients with Psoriatic Arthritis. [PDF]

Curr Issues Mol Biol
Perković D, Petrić M, Maleš M, Erceg Maleš I, Radić M.   +4 more
europepmc   +1 more source

Monotherapy Versus Combination Therapy of Janus Kinase Inhibitors With Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) in Rheumatoid Arthritis: Evidence From a Systematic Review of Randomized Controlled Trials. [PDF]

Cureus
Mirghani Idris RG, Mohammed Nogod AA, Mohamedalamin E, Ahmed Elhaj FM, Yousif Musa AW, Mohammed Mansoor ME, Elagab EA.   +6 more
europepmc   +1 more source

Cancer risk of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs among older Americans with rheumatoid arthritis. [PDF]

Rheumatology (Oxford)
Ahmed S, Pfeiffer RM, Jackson SS, Song M, Mariette X, Seror R, Engels EA.   +6 more
europepmc   +1 more source

Electrochemical evaluation of expired antirheumatic and anti-inflammatory drug (Ardosons) as corrosion inhibitor for API 5L X65 steel in 1M HCl aqueous solution

J.A. Ramírez-Cano, Araceli Espinoza-Vázquez, Kathya Raemy Campos-Anaya, Ricardo Galván-Martínez, Andrés Carmona-Hernández, Ricardo Orozco-Cruz   +5 more
openalex   +2 more sources

Real-world use of biologic and targeted synthetic disease-modifying antirheumatic drugs in US patients with psoriatic arthritis: Persistence, patient characteristics associated with discontinuation, and dosing patterns. [PDF]

J Manag Care Spec Pharm
Merola JF, Welby S, Roque H, Song J, Pilipczuk O, Lu C, Walsh JA.   +6 more
europepmc   +1 more source

Structural and Functional Outcomes in Rheumatoid Arthritis After 10-Year Therapy with Disease-Modifying Antirheumatic Drugs Under Tight Control: Evidence from Real-World Cohort Data. [PDF]

J Clin Med
Mori S, Okada A, Shimizu T, Takatani A, Koga T.   +4 more
europepmc   +1 more source

The connection between the use of nonsteroidal antirheumatic drugs and increased blood pressure

Martinović, Nikola Zvonimir, Miholić, Borna   +1 more
openalex   +2 more sources

Effects of Analgesic and Antirheumatic Drugs on the Assay of Serum Enzymes

, 1984
Z. Jelić, Nada Majkić‐Singh, Snežana Spasić, P Todorović, D. Živanov‐Stakić   +4 more
openalex   +2 more sources

Personalized dose reduction strategies for biologic disease-modifying antirheumatic drugs for treating axial spondyloarthritis: a clinical and economic evaluation with predictive modeling. [PDF]

BMC Rheumatol
Binh BH, Phuong NTT, Hang VTT, Nhan NTT, Hoa NTN, Van Dung H.   +5 more
europepmc   +1 more source